Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONC.TO | HBP.TO | METX.CN | ||
| Company | Oncolytics Bio | Helix Biopharm | ME Therapeutics Holdings Inc. | ||
| Price Information | |||||
| Exchange | TSX | TSX | CNSX | ||
| Open | 1.42 | 2.32 | 4.0000 | ||
| High | 1.44 | 2.40 | 4.0000 | ||
| Low | 1.39 | 2.25 | 4.0000 | ||
| Latest | 1.42 | 2.40 | 4.0000 | ||
| Change | +0.03 | +0.11 | unch | ||
| % Change | +2.16% | +4.80% | unch | ||
| Volume | 109,627 | 3,281 | 0 | ||
| 20-Day Average Volume | 310,431 | 2,437 | 1,150 | ||
| Previous Close | 1.39 | 2.29 | 4.0000 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.36 | 2.27 | 3.8375 | ||
| 20-Day Raw Stochastic | 69.05% | 100.00% | 98.06% | ||
| 20-Day Relative Strength | 54.28 | 55.26 | 47.64 | ||
| Weighted Alpha | -41.60 | +57.23 | -32.49 | ||
| Today's Opinion | 80% Buy | 88% Buy | 88% Sell | ||
| Previous Opinion | 80% Buy | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.70% since 08/15/25 | +17.07% since 12/15/25 | +0.25% since 12/03/25 | ||
| Low | 1.33 on 08/20/25 | 2.03 on 12/16/25 | 3.9900 on 12/05/25 | ||
| High | 1.48 on 08/18/25 | 2.40 on 12/23/25 | 4.0000 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | -14.97% since 07/22/25 | +3.45% since 11/21/25 | unch since 11/14/25 | ||
| Low | 1.13 on 08/08/25 | 2.03 on 12/16/25 | 2.9900 on 12/01/25 | ||
| High | 1.68 on 07/23/25 | 2.40 on 12/23/25 | 4.0200 on 11/21/25 | ||
| 3-Month | |||||
| %Chg | +153.57% since 05/22/25 | +50.00% since 09/23/25 | +23.08% since 09/19/25 | ||
| Low | 0.44 on 06/06/25 | 1.51 on 09/26/25 | 2.5000 on 10/01/25 | ||
| High | 1.85 on 07/17/25 | 5.40 on 10/06/25 | 8.0000 on 10/23/25 | ||
| 6-Month | |||||
| %Chg | +37.86% since 02/21/25 | +158.06% since 06/23/25 | -60.00% since 06/13/25 | ||
| Low | 0.44 on 06/06/25 | 0.84 on 06/30/25 | 2.5000 on 10/01/25 | ||
| High | 1.85 on 07/17/25 | 5.40 on 10/06/25 | 9.5000 on 07/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 142,513 | 183,307 | 120,198 | ||
| Shares Outstanding, K | 100,361 | 76,378 | 30,049 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -31,710,000 | -5,205,000 | -1,193,200 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -14,400,000 | -1,008,000 | -338,413 | ||
| 60-Month Beta | 0.80 | 0.37 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | -0.01 on 12/12/25 | -0.01 | ||
| Latest Earnings Date | 11/11/25 | 12/15/25 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||